Main Article Content
Aim and Objective: The present study is aimed to carry out the effect of the type of GnRH analogue on embryo cleavage. Materials and Methods:A total of 403 patients who underwent Intra Cytoplasmic sperm injection were included in the study .They were divided in to three groups. Group I- Embryos which cleaved before 27 hours after injection. Group II- Embryos which cleaved after 27 hours, Group III-Embryos which cleavaed before and after 27 hours. The effects of GnRh agonist and antagonist on embryo cleavage were compared between the three groups. Results: All the 403 patients were analysed. There was no difference in the mean age, duration of ovarian stimulation, number of oocytes retrieved, fertilization, cleavage rates and embryo quality between the three groups. Out of 403 patients, early cleavage was observed in 165 patients (40.94 %). Late cleavage was observed in 129 patients (32.01%), both early and late cleavage was observed in 109 patients(27.05%).Out of 227 patients in the agonist protocol the early cleavage was observed in 98 patients (43.17%), late cleavage was observed in 71patients (31.28%),and both early and late cleavage was observed in58 patients (25.55%). Out of 176 patients in the antagonist protocol the early cleavage was observed in 67 patients (38.07%), late cleavage was observed in 58 patients (32.95%), and both early and late cleavage was observed in 51 patients (28.98%) P 0.563. We observed there was no statistical significant difference between agonist and antagonist stimulation protocol on embryo cleavage Conclusion: The embryo cleavage was not affected by the type of GnRHanalogue used.
KEYWORDS: Early cleavage; Embryo quality; Intracytoplasmic sperm injection; Ovarian stimulation.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
The submitted papers are assumed to contain no proprietary material unprotected by patent or patent application; responsibility for technical content and for protection of proprietary material rests solely with the author(s) and their organizations and is not the responsibility of the journal. The main (first/corresponding) author is responsible for ensuring that the article has been seen and approved by all the other authors. It is the responsibility of the author to obtain all necessary copyright release permissions for the use of any copyrighted materials in the manuscript prior to the submission.
What are my rights as an author?
It is important to check the policy for the journal to which you are submitting or publishing to establish your rights as
Author. Journal's standard policies allow the following re-use rights:
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to obtain publishing rights without restrictions.
- You may do whatever you wish with the version of the article you submitted to the journal.
- Once the article has been accepted for publication, you may post the accepted version of the article on your own personal website, your department's website or the repository of your institution without any restrictions.
- You may not post the accepted version of the article in any repository other than those listed above (i.e. you may not deposit in the repository of another institution or a subject-matter repository) until 12 months after publication of the article in the journal.
- You may use the published article for your own teaching needs or to supply on an individual basis to research colleagues, provided that such supply is not for commercial purposes.